Latest filing published 16 Oct 2026 for Akari Therapeutics Plc, €62k.
Insider track record
Raymond Prudo-Chlebosz: trading record in brief
All filings by Raymond Prudo-Chlebosz on record concern Akari Therapeutics PLC. Between 31 May 2024 and 5 October 2026, the trades on record add up to 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 16 October 2026, the filings show a share grant worth €62k in Akari Therapeutics PLC. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Raymond Prudo-Chlebosz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,072 shares@ US$7.899American Depositary Shares representing Ordinary SharesSEC:0001493152-26-047458:0
- 3,240 shares@ US$7.899American Depositary Shares representing Ordinary SharesSEC:0001493152-26-047458:1
- 446,428 shares@ US$1.1222.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-25-036487:0
- 419,286,000 shares@ US$0.001223.4% of flowOrdinary Shares, par value $0.0001 per shareSEC:0000950170-24-132929:0
- 1,326,258,000 shares@ US$0.000953.9% of flowOrdinary Shares, par value $0.0001 per shareSEC:0000950170-24-068770:0
5 of 5 declarations
